Results 221 to 230 of about 439,037 (382)

Regulatory framework for genetically modified organisms in the Kingdom of Eswatini. [PDF]

GM Crops Food
Nkhabindze BZ, Magagula CN, Earnshaw D, Mhlanga CF, Matsebula SN, Dladla IG.   +5 more
europepmc   +1 more source

FOOD SAFETY OF GENETICALLY MODIFIED ORGANISM ACCORDING TO INTERNATIONAL LAW AND ITS IMPLEMENTATION IN INDONESIA

, 2020
Risa Mahdewi, Desia Rakhma Banjarani
openalex   +2 more sources

Hybrid Nanofibers for Multimodal Accelerated Wound Healing

Advanced Healthcare Materials, EarlyView.
Fabrication of wound healing scaffolds based on biocompatible nanofibers. Nanofibers offering high surface area, flexibility, and biocompatibility significantly improved the healing outcome in vivo. Histological, immunological, and anti‐inflammatory markers are noticeably better in treated wounds.
Viraj P. Nirwan, Bence Bajusz, Norbert Fabók, Marina Rudan Dimlic, Jelena Budimir, Tshepang Mqatywa, Miklós Gyöngy, Márton Ferencz, Dorottya Kocsis, Olexandr Bondarenko, Mariia Rolduhina, Milena Lengyel, Istvan Antal, Rebecca Hengsbach, Franciska Erdő, Amir Fahmi   +15 more
wiley   +1 more source

Current Patent Protection Granted for Genetically Modified Organisms under the European Patent Convention and the Scandal of EP 0695351

, 2002
Karen A. Spindler
openalex   +1 more source

Biosafety by definition: an analysis of the New Zealand Environmental Protection Authority’s reasons for not classifying organisms treated with double-stranded RNA as genetically modified or new organisms

, 2018
Jack A. Heinemann
openalex   +1 more source

Peptomer Linkers Enable Kinetic Control over Co‐Delivery of Multiple Chemotherapeutics

Advanced Healthcare Materials, EarlyView.
A key challenge in combinatorial chemotherapeutic drug delivery is independent control over release kinetics, especially with drugs of similar size and structure. Here, peptoid substitutions to proteolytically degradable peptides enabled the design of fast and slow‐releasing drug linkers.
Carolyn M. Watkins, Samuel L. Hallam, Mariah J. Austin, Adrianne M. Rosales   +3 more
wiley   +1 more source

How scary! An analysis of visual communication concerning genetically modified organisms in Italy

Public Understanding of Science, 2017
V. Ventura, D. Frisio, G. Ferrazzi, Elena Siletti   +3 more
semanticscholar   +1 more source

Characterization of Microplastics in Human Gastric Cancer and Control Tissues and Analysis of Associated Genetic Features

Advanced Healthcare Materials, EarlyView.
This study characterizes the presence of microplastics in human normal gastric, para‐tumor, and gastric tumor tissue and confirms the association between microplastic exposure and lymph node metastasis in gastric cancer. This study explores the transcriptomic changes induced by microplastic exposure, laying the foundation for further investigation into
Liqiao Chen, Jialin Li, Yan Wu, Han Bao, Xuesong Yang, Guoqing Lv, Ke Ji, Ji Zhang, Xiaojiang Wu, Kai Zhou, Jieli Xu, Jiatian Tang, Xiyuan Han, Anqiang Wang   +13 more
wiley   +1 more source

Costs of Processing Genetically Modified Organisms: Analysis of the Rapeseed and Corn Industries [PDF]

, 2007
Jana-Christina Gawron, Ludwig Theuvsen, Gawron, Jana-Christina, Theuvsen, Ludwig   +3 more
openalex   +1 more source

Microneedle Technology in Psoriasis Management: Mechanistic Insights, Technological Innovation, Clinical Progress, and Challenges

Advanced Healthcare Materials, EarlyView.
This review explores the evolving role of microneedle systems in psoriasis management, highlighting their potential for enhanced drug delivery, diagnosis, and disease monitoring. It also discusses unmet clinical needs for psoriasis management and technical challenges, while outlining strategic directions to advance microneedle integration into routine ...
Fatma Moawad, Yasmine Ruel, Roxane Pouliot, Davide Brambilla   +3 more
wiley   +1 more source